Skip to content
TrialScanner

NCT03393884

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

Phase 1/Phase 2Active, not recruitingIMNNLead

Registry record

Lead sponsor
Imunon
Conditions
Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
Primary completion
Jul 25, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03393884 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03393884: Study of IMNN-001 (Also... | TrialScanner